← Back to Search

Other

SEDA for Hearing Loss

N/A
Recruiting
Led By David M. Landsberger
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 12 years of age
Must not have
Anyone who is not a cochlear implant user or is aged under 12 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to year 2 (completion of experiment 1.2)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how well a noise reduction algorithm can help cochlear implant users ages 12+ understand speech better in different sound environments.

Who is the study for?
This trial is for cochlear implant users who are at least 12 years old and have been using their implant for over six months. Participants must be post-lingually deafened, meaning they lost hearing after acquiring language skills, and considered able to complete the study by the principal investigator.
What is being tested?
The trial is testing a new noise reduction algorithm called SEDA in various listening environments. The goal is to see if it helps people with cochlear implants understand speech better when there's background noise.
What are the potential side effects?
Since this trial involves a software algorithm rather than medication or invasive procedures, traditional side effects are not expected. However, participants may experience fatigue or frustration during testing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 12 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not use a cochlear implant and am 12 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to year 2 (completion of experiment 1.2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to year 2 (completion of experiment 1.2) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of Words Correctly Recognized in Noisy Conditions with Clinical NR
Percent of Words Correctly Recognized in Noisy Conditions with SEDA NR
Percent of Words Correctly Recognized in Noisy Conditions without NR
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cochlear Implant UsersExperimental Treatment1 Intervention
Participants will complete up to 4 experiments evaluating the use of the Speech Enhancement using Dynamic thresholding Approach (SEDA) algorithm. Each testing session will take between 4-6 hours to complete. Testing sessions will continue until the completion of the experiments.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,409 Previous Clinical Trials
855,525 Total Patients Enrolled
16 Trials studying Hearing Loss
2,144 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
353 Previous Clinical Trials
181,417 Total Patients Enrolled
60 Trials studying Hearing Loss
21,430 Patients Enrolled for Hearing Loss
David M. LandsbergerPrincipal InvestigatorNYU Langone Health

Media Library

SEDA (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05805384 — N/A
SEDA (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05805384 — N/A
Hearing Loss Research Study Groups: Cochlear Implant Users
Hearing Loss Clinical Trial 2023: SEDA Highlights & Side Effects. Trial Name: NCT05805384 — N/A
~7 spots leftby Mar 2025